www.elitecme.com | 2019 | INFECTIOUS DISEASE, DISASTER PLANNING & WOUND CARE 35 Disclaimer The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition ©2018: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Elite Professional Education, LLC. The materials presented in this course are meant to provide the consumer with general informa- tion on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Elite Professional Education, LLC rec- ommends that you consult a medical, legal, or professional services expert licensed in your state. Elite Professional Education, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or war- rant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers. Reviewer: Allison Saran, RN, CNM, WHNP-BC Audience: Advanced Nurse Practitioners (ANPs) have responsibilities that extend far beyond admin- istering immunizations: ANPs are challenged to understand the significance of common communi- cable diseases, their prevention, education, recogni- tion, and care. Course overview: This educational program is designed to provide an overview of measles, mumps, and rubella. It covers important information related to their history, epidemiology, symptoms, compli- cations, prevention, and potential treatments. Since the MMR vaccine product is proven to be effective in the prevention of all three diseases, its use will be described in detail adequate to facilitate its usage as a foundation of contemporary care. Communicable diseases, once on the cusp of being eliminated, continue to show up in the United States (U.S.). This course endeavors to illustrate the significant value of maintaining high immuni- zation rates, especially in vulnerable populations. This approach is critical to sustaining low levels of vaccine-preventable illnesses. ANPs, as immuniza- tion providers, are perfectly poised to ensure that vaccinations are administered in a timely manner to everyone who needs them. Strict adherence to communicating the importance of immunizations, vaccination schedules, and patient education on the safety of vaccinations, is essential to maintaining high immunization levels. This course also presents strategies for prevention, education, recognition, and care. LEARNING OBJECTIVES • Understand the hazards of infectious diseases to humans; • Provide two common symptoms associated with measles, mumps, and rubella; • List two potential complications associated with measles, mumps, and rubella; • Describe potential methods for diagnosing mea- sles, mumps, and rubella; • Discuss potential post-exposure prophylaxis treatments appropriate for use after exposure to measles, mumps, or rubella; • Describe differences between the adult and child immunization schedules for vaccination against measles, mumps, and rubella; • List two contraindications and precautions for vaccination against measles, mumps, and rubella using the MMR vaccine product; • Discuss two strategies that can be used to improve immunization rates. Accreditations and Approvals: Elite is accred- ited as a provider of continuing education by the American Nurses Credentialing Center’s Commission on Accreditation. Individual State Nursing Approvals In addition to states that accept ANCC, Elite is an approved provider of continuing education in nursing by:  Alabama, Provider #ABNP1418 (valid through March 1, 2021); California Board of Registered Nursing, Provider #CEP15022; District of Columbia Board of Nursing, Provider # 50-4007; Florida Board of Nursing, Provider #50-4007; Georgia Board of Nursing, Provider #50-4007; and Kentucky Board of Nursing, Provider #7-0076 (valid through December 31, 2019).  This CE program sat- isfies the Massachusetts Board’s regulatory require- ments as defined in 244 CMR5.00: Continuing Education. Activity Director June D. Thompson, DrPH, MSN, RN, FAEN Lead Nurse Planner Disclosures Resolution of Conflict of Interest In accordance with the ANCC Standards for Commercial Support for continuing education, Elite implemented mechanisms prior to the planning and implementationofthecontinuingeducationactivity,to identifyandresolveconflictsofinterestforallindividu- alsinapositiontocontrolcontentofthecourseactivity. Sponsorship/Commercial Support and Non-Endorsement It is the policy of Elite not to accept commercial sup- port. Furthermore, commercial interests are pro- hibited from distributing or providing access to this activity to learners. http://www.cdc.gov/mmwr/preview/ mmwrhtml/rr6204a1.htm • Merck & Co. (2017). Package insert for ProQuad. Retrieved 02 Feb 2018 from http:// www.merck.com/product/usa/pi_circulars/p/ proquad/proquad_pi.pdf • Merck & Co. (2017-1). Package insert for MMR II. Retrieved 03 Feb 2018 from https:// www.merck.com/product/usa/pi_circulars/m/ mmr_ii/mmr_ii_pi.pdf • Minnesota Department of Health. (2016). Measles Clinical Information. Retrieved 01 Feb 2018 from http://www.health.state.mn.us/ divs/idepc/diseases/measles/hcp/clinical.pdf • Morbidity and Mortality Weekly Report (MMWR). (1999). Achievements in Public Health, 1900-1999 Impact of Vaccines Universally Recommended for Children -- United States, 1990-1998. Retrieved 31 Jan 2018 from https://www.cdc.gov/mmwr/pre- view/mmwrhtml/00056803.htm • National Health Service (NHS). (2015). Measles. Retrieved 01 Feb 2018 from https:// www.nhs.uk/conditions/measles/symptoms/ • National Health Service (NHS). (2015- 1). Mumps. Retrieved 04 Feb 2018 from https://www.nhs.uk/conditions/mumps/ complications/ • National Vaccine Information Center (NVIC). (n.d.). Can Measles Vaccine Cause Injury & Death? Retrieved 03 Feb 2018 from http:// www.nvic.org/vaccines-and-diseases/Measles/ measles-vaccine-injury-death.aspx • Patterson, K.B. & Runge, T. (2002). Smallpox and the Native American. Am J Med Sci. 323:216-22. • Public Health England (PHE). (2014). Measles, Mumps, Rubella (MMR): Use of Combined Vaccine Instead of Single Vaccines. Retrieved 06 Feb2018 from https://www.gov. uk/government/publications/mmr-vaccine- dispelling-myths/measles-mumps-rubel- la-mmr-maintaining-uptake-of-vaccine • Sowards, W. (2016). What was the Plague of Justinian? How a Single Outbreak killed 10% of the World’s Population. Retrieved 04 Jan 2018 from https:// www.passporthealthusa.com/2016/05/ what-was-the-plague-of-justinian/ • Sugishita, Y., Akiba, T., Sumitomo, M, et al. (2016). Shedding of Rubella Virus among Infants with Congenital Rubella Syndrome Born in Tokyo, Japan, 2013‚Äì2014. Jpn. J. Infect. Dis. 69: 418‚Äì423. |  CONTINUING EDUCATION